Literature DB >> 576269

Albumin. 2. Guidelines for clinical use.

J L Tullis.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 576269     DOI: 10.1001/jama.237.5.460

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  An audit of blood component therapy in a Canadian general teaching hospital.

Authors:  W F Brien; R J Butler; M J Inwood
Journal:  CMAJ       Date:  1989-04-01       Impact factor: 8.262

2.  Progress in transfusion therapy and treatment of bleeding problems in aortic aneurysm surgery.

Authors:  M M Worthington
Journal:  World J Surg       Date:  1980-09       Impact factor: 3.352

3.  Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study.

Authors:  Akinori Kasahara; Keiji Kita; Eiichi Tomita; Jouji Toyota; Yasuharu Imai; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

4.  Albumin bolus administration versus continuous infusion in critically ill hypoalbuminemic pediatric patients.

Authors:  A Greissman; P Silver; L Nimkoff; M Sagy
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

5.  Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain.

Authors:  Gerardo Avila-Martin; Iriana Galan-Arriero; Julio Gómez-Soriano; Julian Taylor
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.